Amphioxus Cell Technologies

Amphioxus Cell Technologies is a specialized biopharmaceutical company that produces best-in-class allogeneic adult stem cells and stem cell-derived factors. The company is a government-licensed cGMP manufacturer, and its clinical-grade stem cells are currently being used in clinical trials for acute myocardial infarction, chronic heart failure, skin photoaging, and ischemic stroke. Stemedica's products are also utilized by research institutions and hospitals for preclinical and clinical (human) trial activities. With the support of the FDA and other international regulatory agencies, Stemedica is developing additional adult allogeneic stem cells for clinical trials targeting other medical indications.